Primary Care Clinics in Cahokia, IL Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Cep America - Illinois Snf, Llp Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Annable Ct, Cahokia, IL 62206 Phone: 618-332-0114 |
Cahokia Health Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 818 Upper Cahokia Rd, Cahokia, IL 62206 Phone: 618-337-2597 Fax: 618-337-2930 |
Cahokia School Based Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 800 Range Ln, Cahokia, IL 62206 Phone: 618-337-3117 Fax: 618-337-3122 |
News Archive
Seniors, Medicare drug coverage and the doughnut hole
A Kaiser Family Foundation study finds that fewer Medicare drug plan enrollees are hitting the coverage gap. Those who are in it, however, bought fewer drugs.
Scientists discover crucial connection in skin formation
Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.
Contrast agent for tumor diagnostics
X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.
Scientists study how our immune system responds to COVID-19 variants
Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not as effective against contemporary variants of the virus.
› Verified 9 days ago